Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $69.1M
Liabilities Breakdown FY2013
Total Liabilities: $36.6M
Asset Breakdown
Total Assets: $69.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.6M | 66.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.6M | 2.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $21.9M | 31.6% |
Liabilities Breakdown
Total Liabilities: $36.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.2M | 6.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $34.4M | 94.0% |